NAME

Vlasios S. Polychronopoulos

DATE OF BIRTH

December 12, 1951

HOME ADDRESS

14 Achilleos str, 153 42 Agia Paraskevi, Athens, Greece

Tel.: -(30210)-601 0035, 601 4276,  cellphone :-306944-444-206

HIGHER EDUCATION

Degree of Medicine, obtained at the Medical School, National University of Athens, Greece

GRADUATION

October 1975

MEDICAL

Since 1975

SPECIALTY – SUBSPECIALTIES

Internal Medicine (1978)

Pneumonology (1980)

Occupational Medicine (1988)

ACADEMIC POSITION

Lecturer, Medical School, National University of Athens, Greece (1982)

DOCTORAL THESIS

Serum levels of lead and lung function in police department traffic officers (1980-1982)

POSTGRADUATE CLINICAL & RESEARCH FELLOWSHIIP

1.6months: Critical Care Department and Lung Function Laboratories, London Chest Hospital (1983-84, London U.K., supervisor Dr. R.M. Rudd)

2.1 week: Laser in Bronchoscopy (1988, Marseille France, supervisor Prof. Dumon and Prof. Shapshay)

3.1 week:  Bronchoalveolar Lavage (1986, Prague Czechoslovakia, supervisor Prof. Voisin)

4.3 months:  Bronchoscopy Chest Clinic- MayoClinic July – October 1996 – Supervisor : Prof. Prakash

5.3 months: Interstitial Lung Disease Unit: Brompton Royal Hospital-LONDON-January 1999-April1999

6.3 months:Pulmonary  Vasculitis: Mayo Clinic-Prof. U.Specks:May 1^st—July 31^st 2007

7 3 months: .Sarcoidosis: Medical University of South Carolina (MUSC)-Charleston, SC, Prof M. Judson.August 1^st-October 31^st.

PRESENT POSITION: HYGEIA  GEN.HOSPITAL ;ATHENS-GREEECE-PAST POSITION:

Director, Department of 3rd Chest Medicine, Sismanoglion General Hospital, Athens, Greece(1997-2012)-Director Chest Dpt A.Fleming Gen.Hospital-Athens:1989-1997

 

WRITING AND EDITING ACTIVITIES

 

 

Clinical Pneumonology (3 volumes) edited by D. Polyzogopoulos and V. Polychronopoulos, 1993  pages : 2870-Paschalidis Editions—2 nd Edition 2005: 3 vol, 3000pages

–3^RD Edition: In Press 2021

2. Physiology of the Lung, edited by V. Polychronopoulos, translated version of J.B. West “Respiratory Physiology”, 1987
3. Pathophysiology of the Lung, edited by V. Polychronopoulos, translated version of J.B. West “Pulmonary Pathophysiology”, 1986
4. Atlas of Bronchoscopy, edited by G. Thalassinos and V. Polychronopoulos, translated version of P. Straddling “Atlas of Bronchoscopy”,Paschalidis Editions: 1996
5. Chest and Cardiac Imaging, edited by V. Polychronopoulos, translated version of R. Eisenberg “Chest and Cardiac Imaging “,Paschalidis Editions 1996
6. Pathophysiology in diffuse interstitial lung diseases (chapter). V. Polychronopoulos. In: Interstitial Lung Diseases, edited by Hellenic Thoracic Society, 1994
7. Metastatic lung neoplasms (chapter). V. Polycrhonopoulos. In: Bronchogenic Cancer, edited by Hellenic Thoracic Society, 1993
8. Unresolving Pneumonia (chapter). V. Polychronopoulos. In : Infectious Disease of the Lung, edited by Medical Association of Athens, 1990
9. Interpretation of lung function testing. V. Polychronopoulos. Edited by Hellenic Thoracic Society, 1991
10. Ventilation (chapter). V. Polychronopoulos. In: Pulmonary Physiology, edited by Hellenic Thoracic Society, 1991

11.Diagnostic and interventional bronchoscopy.  Postgraduate Course, Hellenic Thoracic Society, 1996

12.Interstitial lung disease. V. Polychronopoulos.  Postgraduate Course, Helliniki Iatriki, 63, sup. 3, 430-525, 1997

13. Organizing Pneumonia Hel. Thorac. Soc. 2004
14. Lung cancer: Classification. Hel. Thorac. Soc. 2004
15. Polychronopoulos V., Kosmas E. Pleural effusion secondary to Gastrointestinal Disease. In: Deckers Pleural Disease; Bouros D: 2004-and 2nd Edition 2008

16.Same as 15 : 3rd Edition ,2010

 17.Clinical Pneumonology  : 3 Volumes-Pages :3070 -Textbook:Edited by :D. Polyzogopoulos and V.  Polychronopoulos-Paschalidis Editions-2005

 18.Pulmonary Circulation.D.Polyzogopoulos-V. Polychronopoulos. In : Pulmonary Physiology-Edited by Hellenic Thoracic Society- 2006

19. Extrinsic Allergic  Alveolitis :Diagnosis and differential diagnosis- V.Polychronopoulos-In: Occupational and Environmental  Lung Diseases-Edited  by  Hellenic Thoracic  Society-2007
20. Acute interstitial and alveolar infiltrates : V. Polychronopoulos-In: Emergency Chest Medicine: Edited by Hellenic Thoracic Society-2008

21.The Chest Physician evaluating the clinicolaboratory findings for the Diagnosis of Interstitial Lung

Disease;Polychronopoulos V and Stagaki H. In Hellenic Thoracic Society :Textbook for the Role of

The Laboratory in the Evaluation of Lung Disease; Athens 2009.

22¨.Common questions in Chest Medicine;Hellenic Thoracic Society 2010: Essentials in Pulmonary Embolism.

23. Diffuse Alveolar Hemorrhage syndromes: chapter 15;E.Stagaki and V.Polychronopoulos;In:S.K.Jindal’s:Textbook of Pulmonary and Critical Care Medicine;JAYPEE Brothers;2010
24. Airway involvement iILDs:S.Tryphon,V.Polychronopoulos,in:

Interstitial Lung Disease;O.Sharma;ED.JAYPEE Brothers,2011

25. Acute Exacerbation of Sarcoidodis;In:.Acute Exacerbation of Respiratory Disease: S.SAHN;ED. :JAYPEE Brothers,2011

I

 ABSTRACTS PRESENTED IN INTERNATIONALMEETINGS AND CONFERENCES : 107

                            THE   MOST IMPORTANT OF THE LAST YEARS

 

    

.1. Frequency and location of Tracheobronchial lesions in Wegener granulomatosis:  Klein         Lorenzo,Jason Golbin Polychronopoulos V ,Prakash U, Specks U. ,Edell E:  CHEST 2008; Philadelphia

2 .Is pleural effusion a common Chest Rx Finding in Pulm.Embolism? E Papageorgiou, V Polychronopoulos et al :CHEST 2008

3  Flow cytometry of BAL Cytokines in pts with IPF and Organizing pneumonia:I. Papanicolaou, V Skouras, V Polychronopoulos et al : CHEST 2008-

4  Pleural fluid B-Type Natriuretic Peptide in Pts with Pleural Effusions ;: Skouras V, Polychronopoulos V, et al : CHEST 2008

5. CTGF and TNFa expression in alveolar  macrophages  of  IPF  patients, before and after treatment wth AZA and IFN:  Xyfteri A, Polychronopoulos V. ,Drakopanagiotakis F. ,Bouros D  et al:

 Oral Presentation at ERS 2009, Vienna

6. Atypical respiratory pathogens in severe COPD exacerbations : Drakopanagiotakis F., Diamantea F., Polychronopoulos V. et al : Poster  Discussion at  ERS  Meeting  2009

7 The efficacy of cytology followup in lung cancer after surgery and chemotherapy A. Emmanouelidou, D. Melemeni, V Polychronopoulos, S Michaelides et al;35^th Eur.Congress of Cytology; Barcelona 2009:

8. Prevelence of common and atypical pathogens in Infectious exacerbations of COPD and their clinical implication: Nakou A, Diamandea F. , Polychronopoulos V. , et al: CHEST Meeting;San Diego 2009.

9.. Pleural fluid CRP as an indicator of prognosis of parapneumonic effusion: Skouras V., Stagaki E, Polychronopoulos V. , et al: CHEST Meeting 2009; San Diego.

10. What is the role of BNP in the diagnostic approach of pleural effusion:Skouras V, Polychronopoulos V, Stagaki E ,et al : CHEST 2010: Poster Session:Vancouver ,29Oct-4 Nov 2010
11. COMMON AND ATYPICAL RESPIRATORY PATHOGENS IN SEVERE COPD EXACERBATION AND PREDICTORS OF POSITIVE SPUTUM CULTURES—

ERS   2010Barcelona–A.Nakou,F.Diamantea,J.Papaparaskevas,I.Michailidou,D.Mermigkis,

N.Karagiannidis,V.Polychronopoulos.

 

12.The impact of depression in recovery and outcome in pts hospitalized for COPD exacerbation; ERS 2011; Amsterdam: A. Papaioannou, K. Kostikas,V.Polychronopoulos et al

 

13: Strong correlation between 18F-DG PET positive bone involvement and increased IL-2R  levels in patients with untreated sarcoidosis  under  surveillance.A. Kalkanis ,V.Polychronopoulos et al:ERS Meeting, 2012-Vienna;

 

 

14: Collateral damage: Depressive  symptoms in the spouses of COPD patients: Papaioannou A, Polychronopoulos V.  Et al:  ERS Annual Meeting; Barcelona 2013

 

15:   18 F-FDG PET scans demonstrate strong  correlation between spleen  metabolism and serum   IL-2R  levels in patients with  untreated  sarcoidosis  under surveillance: A.Kalkanis ,V.Polychronopoulos ,et al: ERS Annual Meeting; Barcelona 2013

 

16: 1,25 –dihydroxyvitamin D in malignant and non malignant pleural effusions: M.Panagiotou, V. Polychronopoulos, et al:

: ERS Annual Meeting; Barcelona 2013

 

 

 

 

 

 

 

 

INVITED LECTURER IN NATIONAL AND INTERNATIONAL MEETINGS: 115

 

(Topics concerning bronchoscopy, pathophysiology,  interstitial lung disease,  and pleural disease)

 

THE  MOST IMPORTANT INTERNATIONAL:

1. Invited Speaker ATS 2006 :THORACIC  PAIN

 

2.Invtited  speaker  at CHEST 2005,2006: Organizing Pneumonia

 

3.Invited   Speaker   APSR-2005  Guangzhou-China: Clinical aspects of  Interstitial Lung Diseaseas

 

4.Invited    Speaker  : CHEST-Pro- Buono Course– Romania-2005 ; Technical  Solutions to common   problems  during  bonchoscopy—Eosinophilic  Lung Disease-

–

5. Invited Speaker : WORLD  Association  of   Bronchology  -Meeting-2006- Buenos Aires- Argentina

 

6. Scientific Organizer and speaker in three Meetings  of  CHEST and Hellenic Thoracic Society-  JUNE-2002-2004-2006- :  Three-days Hands on- Teaching Seminar  on Bronchoscopy

 

7.Invited speaker in Brown University, Sept 2007: Technical solutions during Bronchoscopy

 

8.Invited speaker in MUSC;Charleston, SC: Organizing Pneumonia

 

9.Invited speaker in Postgratuated Course of Hellenic Thoracic Society-Athens-Dec 2007:Nomenclature of the Bronchoscopy findings

 

10. Invited Speaker at Pro-Bono Course;Argentina, Buenos Aires, June 2008 and Targue Mures and Buchurest (Romania), 2005 and 2006.

 

11.Invited Speaker: International WASOG  Meeting Charleston,SC, 2009: Bronchoscopic findings in Wegener.

 

12.Scientific Organizer and Speaker of International Pulmonary Board Review:ACCP-Hellenic Thoracic Society : June 2009 Kavouri-Athens( Topics : ILDs, Alveolar Hemorrhagic Syndromes)

 

13.Invited Speaker  at  APSR 2009,Seoul, South Korea –Topics: Acutre Respiratory Failure due to ILD; Differential Diagnosis of ILDs;  Clinical Evaluation of Thoracic Pain; Technical Solutions to Common Problems during Fiberoptic Bronchoscopy—13-19  November 2009.

 

14 Invited Speaker at Gulf Thoracic Society-ACCP   Meeting: Abu-Dhabi ,March 17-20: Static and Dynamic Lung Volumes-DLCO

 

15. Ivited Speaker at Internatronal Meeting for Lung Cancer: Bronchoscopy findings in lung cancer; June 2010, Samos,Greece.

 

16. Invited Speaker at Bulgarian Respiratory Society National Meeting: Plovdiv,

June 2010:Diffuse Alveolar Hemorrhage.

 

17. Invited Speaker at International Meeting of World Association of Bronchology; June 2010:

Tracheobronchial Manifestations in Sarcoidosis and Wegener Granulomatosis.

 

18: Chairman-Speaker at 4^th Hands-on Meeting of ACCP-Hellenic Thoracic Society; Athens, June 2010: (a): Nomenclature of Endobronchial Findings.

          (b) Casualties during fiberoptic Bronchoscopy.

 

19: Invited speaker at CHEST 2010 MEETING:  Vancouver ,Oct 29-Nov4 :Global challenges

In the Management of Asthma;  Sunday,,Oct31th.-Ivited Expert at :Drug induced Lung Disease

Invited Moderator for Lung Cancer Posters.

 

20: Invited speaker at Egyptian Bronchology Society Meeting; Cairo , 2010, December 2-4 

 

21: Organiser and Speaker at: 2^nd  HTS/ACCP Pulmonary Board Review Meeting in Athens, June 2012: Difuse Lung Disease: Diagnostic Strategy.

 

22. ERS School ,6-8  July 2012: Speaker : Pulmonary Vasculitis

 

23. 3^rd International Lung Cancer Seminar;6-8 September 2012: Speaker:Lung Cancer Screening: To Whom? 4.Invited Speaker: 2^nd  ECBIP Meeting: Izmir, April 2013: Bronchoscopic or Surgical Diagnosis in Interstitial Lung Disease?

 

25.Invited Speaker : 35^th Annual Meeting of Turkish Thoracic Society: Izmir, October 4-7, 2013;Topics: Organizing Pneumonia and Diffuse Alveolar Hemorrhage.

 

26: Invited Speaker: 22th HTS Annual Meeting-ERS School: Lung Mechanics in Interstitial Lung Diseases: 5 Dec 2013, Athens –Greece

 

27: Invited  Speaker : 1^st WORLD CHEST ,Madrid, March 21-24  2014: Thoracic  Pain.

28:Invited Speaker:HTS-ERS Hermes School: Athens, August 2014: Pulmonary Vasculitis

 

29.Invited Speaker : 1^st Pulmonary Board Review: ACCP/Izmir: Oct 2014: Pulmonary Embolism.

 

 

30. Invited Speaker: CONFERENCE ON LUNG CANCER:Best of 16TH WCLC: Risk factors for Lung Cancer;HILTON, ATHENS-January 14-15, 2016

 

31: Invited Speaker: University of Athens: Oncology Dpt: Prof.Syrigos: Lung Cancer and ILD-

2016,2017,2018-

 

32: Invited Speaker: National Congress in Pulmonology: Athens, 2017: Interstitial Lung Disease

 

33: : Invited Speaker: National Congress in Pulmonology: Thessaloniki , 2018: (a)Technical Solutions to common problems during Fiberoptic Bronchoscopy-(b)-Chairman: Pulmonary Embolism

 

34: : Invited Speaker: University of Athens:Prof . Zakynthinos S. : Differential diagnosis of ILDs.Evaggelismos Hosp, 5/2019

 

35:  Invited Speaker: Hellenic Thoracic Society: 4/2018: Pathogenesis of Tuberculosis-

 

36: Scientific  Collaborator of Dpt of Pathological Physiology of Athens University:

Lectures to Students at 3 rd and 6^th year of Medical School- 2012-2019

 

37: Coordinator and Faculty Member: 3^rd ACCP/HTS  Meeting ,Athens 2019—June, Megaron Moussikis-

 

38:Invited Speaker : University of Athens:Prof . Zakynthinos S. :Thoracic Pain-Evangelismos Hospital, Sept 2020

 

 

 

 

 

 

 

PUBLICATIONS IN NATIONAL

MEDICAL JOURNALS  :   33

 

 

 

 

 

PUBLISHED ARTICLES IN PEER REVIEWED INTERNATIONAL JOURNALS :  49

                                THE   MOST  IMPORTANT:

1. How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study.

Kampolis CF, Venetsanopoulou AI, Karakontaki F, Polychronopoulos V, Vlachoyiannopoulos P, Tzioufas AG.

Autoimmun Rev. 2018 Sep 10. pii: S1568-9972(18)30214-3. doi: 10.1016/j.autrev.2018.06.004. [Epub ahead of print] Review.

 

2. Respiratory and lower limb muscle function in interstitial lung disease.

Panagiotou M1, Polychronopoulos V2, Strange C3

-Chron Respir Dis. 2016 Jan 14–

 

 

3.. A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease.

Nakou A1, Papaparaskevas J, Diamantea F, Skarmoutsou N, Polychronopoulos V, Tsakris A.

Future Microbiology;2014,November ,,1251

 

• Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis.—62 Citations—(Aug.2017)

Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V.

Chest. 2011 Apr;139(4):893-900. doi: 10.1378/chest.10-0883. Epub 2010 Aug 19.

 

 

5.Acute exacerbations of interstitial lung diseases.

Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS.

Citations: 15-Aug 2017

Curr Opin Pulm Med. 2010 Sep;16(5):480-6. doi: 10.1097/MCP.0b013e32833ae49d. Review.

 

6.

23.Airway involvement in sarcoidosis.    59 Citations Aug 2017–

Polychronopoulos VS, Prakash UB.

Chest. 2009 Nov;136(5):1371-80. doi: 10.1378/chest.08-2569. Review.

7. 32.Organizing pneumonia.—-42 Citations—Aug.2017–

Drakopanagiotakis F, Polychronopoulos V, Judson MA.

Am J Med Sci. 2008 Jan;335(1):34-9. doi: 10.1097/MAJ.0b013e31815d829d. Review.

 

8. 33.Airway involvement in Wegener’s granulomatosis.—

42 Citations—Aug.2017—

Polychronopoulos VS, Prakash UB, Golbin JM, Edell ES, Specks U.

Rheum Dis Clin North Am. 2007 Nov;33(4):755-75, vi. Review.

 

9. .Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. 93 Citations –Aug 2017–

Rice AJ, Wells AU, Bouros D, du Bois RM, Hansell DM, Polychronopoulos V, Vassilakis D, Kerr JR, Evans TW, Nicholson AG.

Am J Clin Pathol. 2003 May;119(5):709-14.

 

10. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.—452 Citations—Aug.2017–

Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM.

Am J Respir Crit Care Med. 2002 Jun 15;165(12):1581-6.

 

11. Acute interstitial pneumonia.—108 Citations—Aug.2017–

Bouros D, Nicholson AC, Polychronopoulos V, du Bois RM.

Eur Respir J. 2000 Feb;15(2):412-8. Review.

 

      

28/10/2020: Cited documents Total  2168